Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy.
J Appl Clin Med Phys
; 24(4): e13899, 2023 Apr.
Article
in En
| MEDLINE
| ID: mdl-36637862
Full text:
1
Database:
MEDLINE
Main subject:
Radiopharmaceuticals
/
Prostatic Neoplasms, Castration-Resistant
/
Lutetium
Limits:
Humans
/
Male
Language:
En
Journal:
J Appl Clin Med Phys
Journal subject:
BIOFISICA
Year:
2023
Type:
Article
Affiliation country:
United States